Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06YMZ
|
|||
| Former ID |
DNC010592
|
|||
| Drug Name |
N-(6-phenethyl-1H-indazol-3-yl)butyramide
|
|||
| Synonyms |
CHEMBL1084684; N-(6-phenethyl-1H-indazol-3-yl)butyramide; SCHEMBL6489338
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H21N3O
|
|||
| Canonical SMILES |
CCCC(=O)NC1=NNC2=C1C=CC(=C2)CCC3=CC=CC=C3
|
|||
| InChI |
1S/C19H21N3O/c1-2-6-18(23)20-19-16-12-11-15(13-17(16)21-22-19)10-9-14-7-4-3-5-8-14/h3-5,7-8,11-13H,2,6,9-10H2,1H3,(H2,20,21,22,23)
|
|||
| InChIKey |
FEGHHCWVRCSXNL-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Rational design of potent GSK3beta inhibitors with selectivity for Cdk1 and Cdk2. Bioorg Med Chem Lett. 2010 Mar 15;20(6):1985-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.